Checkpoint-Inhibitors Archive - IOZK

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1

2021-11-02/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, NSCLC, SCLC /von 2021-11-02 / Cancers (Basel) 2021 Nov;13(21)

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy

2021-07-19/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2021-07-19 / Sci Rep 2021 Jul;11(1):14661

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials

2020-11-16/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-11-16 / Int J Mol Sci 2020 Nov;21(22)

Emerging Immunotherapies in the Treatment of Brain Metastases

2020-10-26/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-10-26 / Oncologist 2020 Oct;

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade

2020-08-07/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-08-07 / Cancer Cell Int. 2020;20:380

Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine

2020-06-21/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2020-06-21 / J Control Release 2020 Jun;326:63-74

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?

2020-03-12/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2020-03-12 / Front Oncol 2020;10:343

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma

2020-02-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2020-02-01 / J Immunother Cancer 2020 02;8(1)

Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine

2019-10-24/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-10-24 / Immunology 2020 01;159(1):75-87

Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization

2019-09-19/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-09-19 / Cancers (Basel) 2019 Sep;11(9)